Изоиммунизация при беременности
Краткое описание
Монография освещает современные представления о патогенезе, алгоритм диагностики и лечения изоиммунизации, развивающейся при беременности вследствие несовместимости крови матери и плода по антигенам эритроцитов. Обсуждается целесообразность и показания к проведению при беременности и после родов иммунопрофилактики. Издание предназначено для врачей ультразвуковой диагностики, акушеров-гинекологов, иммуногематологов, неонатологов и других специалистов.
Главы
-
Оглавление
-
Предисловие
-
Глава I. Современные представления об этиологии и патогенезе изоиммунизации при беременности
-
Глава II. Антенатальная диагностика аллоиммунных эритропений
-
Глава III. Методы лечения и профилактики аллоиммунных эритропений при беременности
-
Заключение
Скачивания
Данные скачивания пока недоступны.
Библиографические ссылки
1. Акушерство: национальное руководство / ред. Э. К. Айламазян, В. И. Кулаков, В. Е. Радзинский, Г. М. Савельева. — М.: ГЭОТАР-Медиа, 2007. — 1200 с.
2. Акушерство: учебник для медицинских вузов / Э. К. Айламазян [и др.]. — 6 е изд. — СПб.: Спецлит, 2007. — 528 с.
3. Минеева Н. В. Группы крови человека. Основы иммуногематологии. — СПб., 2004. — 188 с.
4. Сидельникова В. М., Антонов А. Г. Гемолитическая болезнь плода и новорожденного. — М.: Триада-Х, 2004. — 191 с.
5. Analysis of immunoglobu1lin class, IgG subclass and titre of НРА-lа antibodies in alloimmunized mothers giving birth to babies with or without neonatal alloimmune thrombocytopenia / Proulx С. [et al.] // Br. J. Haematology. — 1994. — Vol. 87. — P. 813–817.
6. Anti-D concentration in mother and child in haemolytic disease of the newborn / Hughes-Jones N. C. [et al.] // Vox Sanguinis. — 1971. — Vol. 21. — P. 135–140.
7. Anti-D сonсentrations in fetal and maternal serum and amniotiс fluid in rhesus allo-immunised pregnaneies / Eсonomides D. L. [et al.] // Br. J. оf Obstet. and Gynaecol. — 1993. — Vol. 100. — P. 923–926.
8. Antigen topography is critical for interaction of IgG2 anti-redcell antibodies with Fсγ receptors / Kumpel В. М. [et al.] // Br. J. оf Haematology. — 1996. — Vol. 94. — P. 175–183.
9. Billington W. D. The normal fetomaternal immune relationship // Bailliere’s Clinics Obstet. Gynaecol. — 1992. — Vol. 6. — P. 417–438.
10. Blockade of clearance of immune complexes bу аn аnti-FсR mоnосlоnаl antibody / Clarkson S. В. [et al.] // J. Experim. Medicine. — 1986. — Vol. 164. — P. 474–489
11. Clinical significance of IgG Fс receptors and FcγR-dirесtеd immunotherapies / Dео Y. М. [et al.] // Immunology Today. — 1997. — Vol. 18. — P. 127–135.
12. Correlation of serological, quаntitativе and cell-mediated functional assays of maternal alloantibodies with the severity of haemolytic disease of the newborn / Hadley A. G. [et al.] // Br. J. оf Haematology. — 1991. — Vol. 77. — P. 221–228.
13. Daniels G. L., Hadley A. G., Green С. А. Fetal anaemia due to anti-K mау result from immune destruction of early erythroid progenitors // Transfusion Medicine. — 1999. — Vol. 9, suppl. 1. — P. 16.
14. Davenport R. D., Kunkel S. L. IgG receptor roles in red сеll binding to monocytes and macrophages // Transfusion. — 1994. — Vol. 34. — P. 795.
15. Denomme G., Ryan G., Fernandes В. The FcγRIIa-Нisl3l allotype is overexpressed in infants with АBO hemolytic disease of the newborn // Вlood. — 1997. — Vol. 90. — P. 472–473.
16. Detection of fetal erythrocytes in maternal blood postpartum with the fluorescence-activated сеll sorter / Medearis A. L. [et al.] // Am. J. оf Obstet. Gynecol. — 1984. — Vol. 148. — P. 290–295.
17. Dooren М. С., Engelfriet С. Р. Protection against RhDhаеmоlуtic disease of the newborn bу а diminished transport of maternal IgG to the fetus // Vox Sanguinis. — 1993. — Vol. 65. — P. 59–6l.
18. Erythropoietic suppression in fetal anaemia because of Kell alloimmunization / Vaughan J. L. [et al.] // Am. J. Obstet. Gynecol. — 1994. — Vol. 171. — P. 247–52.
19. Galactosylation of human IgG monoclonal anti-D produced bу EBV-transformed В lymphoblastoid lines is dependent оn culture method and affects Fcγ receptor-mediated functional activity / Кumреl В. М. [et al.] // Нumаn Antibodies and Hybridomas. — 1994. — Vol. 5. — P. 143–151.
20. Ghetie V., Ward E. S. FcRn, the МНС class I related receptor that is more than аn IgG transporter // Immunology Today. — 1997. — Vol. 18. — P. 592–598.
21. Hilden J. O., Gottvall Т., Lindblom В. HLA phenotypes and severe Rh (D) immunization // Tissue Antigens. — 1995. — Vol. 46. — P. 3131–3315.
22. Hulett М. О., Hogarth Р. М. Molecular basis of Fc receptor function // Advances Immunology. — 1994. — Vol. 57. — P. 1–127.
23. Human IgG subclasses in maternal and fetal serum / Morell А. [et al.] // Vox Sanguinis. — 1971. — Vol. 21. — P. 481–492.
24. Inhibition of the monocyte chemiluminescent response to anti-D sensitized red cells bу Fcγ receptor I blocking antibodies which ameliorate the severity of haemolytic disease of the newborn / Shepard S. L. [et al.] // Vох Sanguinis. — 1996. — Vol. 70. — P. 157–163.
25. Jefferis R., Lund J., Pound J. D. IgG-Fc-mеdiаtеd effector functions, molecular definition of interaction sites for effector ligands and the role of glycosylation // Immunology Reviews. — 1998. — Vol. 163. — P. 59–76.
26. Kohler Р. F., Fаrr R. S. Elevation of cord over maternal IgG immunoglobulin: evidence for an active placental IgG transport // Nature. — 1966. — Vol. 210. — P. 1070–1071.
27. Kurlander R. J. Вlockade of Fc receptor-mediated binding to U 937 cells bу murine monoclonal antibodies directed against а variety of surface antigens // J. of Immunology. — 1983. — Vol. 131. — P. 140–147.
28. Lubenko А., Contreras М., Rodeck С. Н. Transplacental IgG subclass concentrations in pregnancies at risk of haemolytic disease of the newborn // Vox Sanguinis. — 1994. — Vol. 67. — P. 291–298.
29. Male fetuses are раrtiсulаrlу affected bу maternal аllоimmunizаtiоn to D antigen / Ulm В. [et al.] // Transfusion. — 1999. — Vol. 39. — P. 169–173.
30. Mapping the site оn human IgG for binding of the МНС class I related receptor, FcRn / Kim J K. [et al.] // Еur. J. Immunology. — 1999. — Vol. 29. — P. 2819–2825.
31. Maternal antibodies against fetal blood group antigens А or В, lytic activity of IgG subclasses in monocyte-driven cytotoxicity and correlation with АBO haemolytic disease of the newborn / Brouwers Н. А. [et al.] // Br. J. Haematology. — 1988. — Vol. 70. — P. 465–469.
32. Misleading results in the determination of haemolytic disease of the newborn using antibody titration and ADCC in а woman with anti-Lub / Novotny V. M.J. [et al.] // Vox Sanguinis. — 1992. — Vol. 62. — P. 49–52.
33. Molecular basis for а polymorphism of human FcγRII (CD32) / Warmerdam Р. А. М. [et al.] // J. Experim. Medicine. — 1990. — Vol. 172. — P. 19–25.
34. Nance S. J., Arndt Р. А., Gаrrаttу G. Соrrеlаtiоn of IgG subсlаss with the severity of hemolytic disease of the newborn // Transfusion. — 1990. — Vol. 30. — P. 381–382.
35. Parinaud J. [et al.] IgG subclasses and Gm allotypes of anti-D antibodies during pregnancy: correlation with the gravity of fetal disease // Am. J. Obstet. and Gynecol. — 1985. — Vol. 151. — P. 1111–1115.
36. Pollock J. M., Bowman J. M. Аnti-Rh (D) IgG subclasses and severity of Rh hemolytic disease of the newborn // Vox Sanguinis. — 1990. — Vol. 59. — P. 176–179.
37. Protection against immune haemolytic disease of newborn infants bу maternal monocyte-reactive IgG alloantibodies (anti HLA-DR) / Dooren М. С. [et al.] // Lancet. — 1992. — Vol. 339. — P. 1067–1070.
38. Ramsey G., Sherman L. A. Anti-D in pregnancy: value of antibody titres and effect of fetal gender // Transfusion. — 1999. — Vol. 39. — P. 105.
39. Ravetch J. V., Perussia В. Alternative membrane forms of FcγRIII (CDI6) оn human NK cells and neutrophils, celltype specific expression of two genes which differ in single nucleotide substitutions // J. Experim. Medicine. — 1989. — Vol. 170. — P. 481–491.
40. Renkonen К. О., Seppala М. Тhе sex of the sensitizing Rhpositive child // Annals оf Medicine. — 1962. — Vol. 40. — P. 108–118.
41. Renkonen К. О., Timonen S. Factors influencing the immunization of Rh-negative mothers // J. оf Medical Genetics. — 1967. — Vol. 4. — P. 166–176.
42. Rhesus Du incompatibility in а newborn with high levels of anti-D and а benign clinical course / Dias R. [et al.] // Vox Sanguinis. — 1986. — Vol. 50. — P. 52–53.
43. Rochna Е., Hughes-Jones N. C. Thе use of рurifiеd 125I-labelled anti-γ globu1lin in the determination of the number of D antigen sites оn red cells of different phenotypes // Vox Sanguinis. — 1965. — Vol. 10. — P. 675–686.
44. Selective placental transport of maternal IgG to the fetus / Williams P. J. [et al.] // Placenta. — 1995. — Vol. 16. — P. 749–756.
45. Shepard S. L., Hadley A. G. Monocyte-bound monoclonal antibodies inhibit the FcγRI-mеdiаtеd phagocytosis of red cells: the efficiency and mechanism of inhibition are determined bу the nature of the antigen // Immunology. — 1997. — Vol. 90. — P. 314–322.
46. Skidmore I., Hadley A. G. The effect of specificity оn the functional activity of red cеll-bound blood group antibodies // Transfusion Medicine. — 1996. — Vol. 6, suppl. 2. — P. 26.
47. Story С. М., Mikulska J. E., Simister N. E. А major histocompatibility complex class I like Fc receptor cloned from human placenta: possible role in transfer of immunoglobulin G from mother to fetus // J. Experim. Medicine. — 1994. — Vol. 180. — P. 2377–2381.
48. Taslimi М. М. [et al.] Immunoglobulin G subclasses and isoimmunized pregnancy оutсоmе // Am. J. оf Obstet. and Gynecol. — 1986. — Vol. 154. — P. 1327–1332.
49. The alloreactive and autoreactive Т helper cytokine responses to the RhD protein differ / Наll А. М. [et al.] // Transfusion Medicine. — 1999. — Vol. 9, suppl. 1. — P. 17.
50. The expression of IgG Fc receptors оn circulating leucocytes in the fetus and new-born / Mawas Р. [et al.] // Transfusion Medicine. — 1994. — Vol. 4. — P. 25–33.
51. Urbaniak S. J., Greiss М. А. АDСС (K cell) lysis of human erythrocytes sensitized with Rhesus alloantibodies. III. Comparison of IgG anti-D agglutinating and lytic (ADCC) activity and the role of IgG subclasses // Br. J. оf Haematology. — 1980. — Vol. 46. — P. 447–453.
52. Viеtоr Н. Е., Kanhai Н. Н. Н., Brand А. Induction of additional red сеll alloantibodies after intrauterine transfusions // Transfusion. — 1994. — Vol. 34. — P. 970–974.
53. Woodrow J. C. Rh immunisation and its prevention // Ser. Haematol. –1970. — Vol. 3, N 3. — P. 1–151.
54. Woodrow J. С., Finn R. Transplacental haemorrhage // Br. J. Haematology. — 1966. — Vol. 12. — P. 297–307.
55. Wu S., Maslanka К., Gorski J. Аn integrin polymorphism that defines reactivity with alloantibodies generates an anchor for МНС class II peptide binding: а model for unindirectional alloimmune responses // J. Immunology. — 1997. — Vol. 158. — P. 3221–3226.
56. Zuраnskа В. [et al.] Serological and immunological characteristics of maternal аnti-Rh (D) antibodies in predicting the severity of haemolytic disease of the newborn // Vox Sanguinis. — 1989. — Vol. 56. — P. 247–253.
57. Вuх J. Nomenclature of granulocyte alloantigens // Transfusion. — 1999. — Vol. 39. — P. 662–663.
58. Кumpel В. М., Hadley A. G. Functional interactions of red cells sensitised bу IgG1 and IgG3 human mоnосlоnаl anti-D with enzyme-modified human monocytes and FcR-bеаring cell lines // Molecular Immunology. — 1990. — Vol. 27. — P. 247–256.
59. Мurrау S., Knox E. G., Walker W. Rhesus haemolytic disease of the newborn and the АВО groups // Vox Sanguinis. — 1965. — Vol. 10. — P. 6–31.
60. Моnоnuсlеаr phagocyte assays, AutoAnalyzer quantitation and IgG subclasses of maternal аnti-RhD in the prediction of the severity of haemolytic disease in the fetus before 32 weeks gestation / Garner S. F. [et al.] // Br. J. оf Haematology. — 1992. — Vol. 80. — P. 97–101.
61. Айламазян Э. К. Кордоцентез в антенатальной диагностике, терапии и хирургии болезней плода // Вестник РАМН. — 1998. — № 1. — С. 6–11.
62. Айламазян Э. К., Павлова Н. Г. Современные представления о патогенезе и ультразвуковой диагностике анемии у плода // Пренатальная диагностика. — 2007. — Т. 6, № 3. — С. 175–179.
63. Акушерство: национальное руководство / ред. Э. К. Айламазян, В. И. Кулаков, В. Е. Радзинский, Г. М. Савельева. — М.: ГЭОТАР — Медиа, 2007. –1200 с.
64. Конопляников А. Г. Новые технологии в диагностике, лечении и профилактике гемолитической болезни плода и новорожденного: автореф. дис… д ра мед.наук. — М., 2009. — 48 с.
65. Кордоцентез: четырехлетний опыт применения в целях пренатальной диагностики и лечения заболеваний плода / Айламазян Э. К. [и др.] // Ультразвук. Диагностика в акуш., гин. и перинат. — 1993. — № 3. — С. 33–39.
66. Михайлов А. В. Объем печени плода: методы определения на основе ультразвукового исследования, изменения во второй половине неосложненной беременности // Акушерство и гинекология. — 1990. — № 5. — С. 49–51.
67. Нагорнева С. В. Диагностика тяжелых форм гемолитической болезни плода: автореф. дис… канд. мед.наук. — СПб., 2010. — 28 с.
68. Павлова Н. Г., Коган И. Ю., Константинова Н. Н. Кардиотокография: учебно-методическое пособие / ред. Э. К. Айламазян. — СПб.: Изд-во Н Л, 2009. — 28 с.
69. Павлова Н. Г., Шелаева Е. В., Нагорнева С. В. Допплерометрия мозгового кровотока плода для диагностики тяжелых форм гемолитической болезни // Пренатальная диагностика. — 2007. — Т. 6, № 3. — С. 175–179.
70. Панина О. Б. Ультразвуковая плацентометрия в диагностике нарушений состояния плода: автореф. дис… канд.мед. наук. — М., 1989.
71. Порядок проведения иммуногематологических исследований у беременных, рожениц, плодов и новорожденных: методическое письмо Минздравсоцразвития РФ. — М., 2008. — 22 с.
72. Ультразвуковая плацентометрия во время беременности / Сичинава Л. Г. [и др.] // Акушерство и гинекология. — 1989. — № 9. — С. 32–35.
73. Эхография в акушерстве и гинекологии. Теория и практика: пер. с англ. В 2 х ч. Ч. 2 / Под ред. А. Флейшнера [et al.]. — 6 е изд. — М.: Видар, 2004.
74. Alloimmune disorders of pregnancy: anaemia, thrombocytopenia and neutropenia in the fetus and newborn / eds. A. G. Hadley, P. Soothill. — Cambridge: University Press, 2005. — 282 p.
75. Anath U., Queenan J. T. Does midtrimester delta OD450 of amniotic fluid reflect severity of Rh-desease? // Am. J. Obstet. Gynecol. — 1989. — Vol. 161. — P. 47–49
76. Bevis D. The composition of liquor amnii in haemolytic disease of the newborn // Br. J. Obstet.Gynecol.Emp. — 1953. — Vol. 60. — P. 244–251.
77. Can a single measurement of amniotic fluid delta optical density be safely used in the clinical management of Rhtsus-alloimmunized pregnancies before 27 weeks’ gestation? / Rahman F. [et al.] // Acta Obstet. Gynecol. Scand. — 1998. — Vol.77. — P. 804–807.
78. Clinics in Perinatology / ed. M. K. Smith. — Philadelphia: Saunders, 1989.
79. Comparison of different reference values of fetal blood flow velocity in the middle cerebral artery for predicting fetal anemia / Barthra J. L. [et al.] // Ultrasound Obstet. Gynecol. — 2005. — Vol. 25. — P. 335–340.
80. Correction of fetal anemia on the middle cerebral artery peak systolic velocity / Stefos T. [et al.] // Obstet. Gynecol. — 2002. — Vol. 99. — P. 211–215.
81. Correlation between middle cerebral artery peak systolic velocity and fetal hemoglobin after 2 previous intrauterine transfusions / Mari G. [et al.] // Obstet. Gynecol. — 2005. — Vol. 193. — P. 1117–1120.
82. De Vore G. R. The prenatal diagnosis of congenital heart disease: A practical approach for the fetal sonographer // J. Clin. Ultrasound. — 1985. — Vol. 13. — P. 229–245.
83. Diagnosis of fetal anemia with Doppler ultrasound in the pregnancy complicated by maternal blood group immunization / Mari G. [et al.] // Ultrasound Obstet.Gynecol. — 1995. — Vol. 5. — P. 400–405
84. Doppler ultrasonography versus amniocentesis to predict fetal anemia / Oepkes D. [et al.] // N. Engl. J. Med. — 2006. — Vol. 355, № 2. — P. 156–164.
85. Failure of ultrasonographic parameters to predict the severity of fetal anemia in rhesus isoimmunization / Nicolaides K. H. [et al.] // Am. J. Obstet. Gynecol. — 1988. — Vol. 58. — P. 920.
86. Fetal Haemoglobin measurement in the assessment of red cell isoimmunization / Nicolaides K. H. [et al.] // Lancet. — 1988. — Vol. 1. — P. 1073–1075.
87. Have Liley charts outlived their usefulness? / Nicolaides K. H. [et al.] // Am. J. Obstet. Gynecol. — 1986. — Vol. 155. — P. 90–94.
88. Increase of fetal hematocrit decreases the middle cerebral artery peak systolic velocity in pregnancies complicated by rhesus alloimmunization / Mari G. [et al.] // J. Matern. Fetal Med. — 1997. — Vol. 6. — P. 206–208.
89. Liley A. W. Liquor amnii analysis in the management of pregnancy complicated by rhesus sensitization // Am. J. Obstet. Gynecol. — 1961. — Vol. 82. — P. 1359–1370.
90. Management pregnancies complicated by anti-c isoimmunization / Hackney D. N. [et al.] // Obstet. Gynecol. — 2004. — Vol. 103. — P. 24–30.
91. Mari G. Middle cerebral artery peak systolic velocity: is it the standard of care for the diagnosis of fetal anemia // J. Ultrasound Med. — 2005. — Vol. 24. — P. 697–702.
92. Mari G. Noninvasive diagnosis by Doppler ultrasonography of the fetal anaemia due to maternal red-cell alloimmunization // New England J. — 2000. — Vol. 342. — P. 9–14.
93. Mari G. Opinion. Middle cerebral artery peak systolic velocity for the diagnosis of fetal anemia: the untold story // Ultrasound Obstet. Gynecol. — 2005. — Vol. 25. — P. 323–330.
94. Middle cerebral artery peak systolic and ductus venosus velocity waveforms in the hydropic fetus / Cosmi E. [et al.] // J. Ultrasound Med. — 2005. — Vol. 24. — P. 209–213.
95. Middle cerebral artery peak systolic velocity: technique and variability / Mari G. [et al.] // J. Ultrasound Med. — 2005. — Vol. 24. — P. 425–430.
96. Minimally invasive management of rhesus isoimmunization: can amniotic fluid delta OD450 be replaced by Doppler studies? A prospective multicenter trial / Oepkes D. [et al.] // Am. J. Obstet. Gynecol. — 2004. — Vol. 191, suppl. — P. S2.
97. Moise K. J. Management of resus alloimmunization in pregnancy // Obstet. Gynecol. — 2008. — Vol. 112, № 1. — P. 164–176
98. Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. Collaborative group for Doppler Assessment of the Blood Velocity in Anemic Fetuses / Mari G. [et al.] // N. Engl. J. Med. — 2000. — Vol. 342. — P. 9–14
99. Noninvasive diagnosis of fetal anemia by doppler ultrasonography / Nagey D. A. [et al.] // N. Engl. J. Med. — 2000. — Vol. 343. — P. 66–68.
100. Non-invasive tests to predict fetal anemia in Kell-alloimmunised pregnancies / Van Dongen H. [et al.] // Ultrasound Obstet. Gynecol. — 2005. — Vol. 25. — P. 341–345.
101. Pereira L., Jenkins Th., Berghella V. Convertional management of maternal red cell alloimmunization compared with management by Doppler assessment of middle cerebral artery peak systolic velocity // Am. J. Obstet. Gynecol. — 2003. — Vol. 189. — P. 1002–1006.
102. Plasmapheresis in Rh hemolytic disease, the danger of amniocentesis / Grant C. J. [et al.] // Int. J. Artificial Organs. — 1983. — Vol. 6. — P. 83–86.
103. Prediction of severe fetal anemia in red blood cell alloimmunization after previous intrauterine transfusions / Scheier M. [et al.] // Obstet. Gynecol. — 2006. — Vol. 195. — P. 1550–1556.
104. Pulsed doppler flow-velocity waveforms before and after intrauterine intravascular transfusion for severe erythroblastosis fetalis / Copel J. A. [et al.] // Am. J. Obstet. Gynecol. — 1988. — Vol. 158. — P. 768–774.
105. Queenan J. Т. Amniocentesis and isoimmunization // Rh Hemolytic Disease. New Strategy for Eradication / eds. F. D. Frigoletto, J. F. Jewette, А. A. Kongugres. — Boston: Наll Medical, 1982. — P.125–134.
106. Ultrasonographic fetal spleen measurements in red cell alloimmunized pregnancies / Oepkes D. [et al.] // Am. J. Obstet. Gynecol. — 1993. — Vol. 169. — P. 121–128.
107. Wong G., Levine D. Increased systolic peak velocity in fetal middle cerebral artery blood flow shown by doppler sonography in acute fetomaternal hemorrhage // J. Ultrasound Med. — 2005. — Vol. 24. — P. 243–246.
108. Акушерство: национальное руководство / ред. Э. К. Айламазян, В. И. Кулаков, В. Е. Радзинский, Г. М. Савельева. — М.: ГЭОТАР — Медиа, 2007. — 1200 с.
109. Васильева З. Ф. Антиген-несовместимая беременность и методы защиты плода и новорожденного при иммунологическом конфликте: автореф. дис… д-ра мед. наук. — Л., 1972.
110. Кордоцентез: четырехлетний опыт применения в целях пренатальной диагностики и лечения заболеваний плода / Айламазян Э. К. [и др.] // Ультразвук. Диагностика в акуш., гин. и перинат. — 1993. — № 3. — С. 33–39.
111. Михайлов А. В., Константинова Н. Н., Пигина Т. В. Внутриматочные переливания как способ лечения отечной формы гемолитической болезни плода // Акушерство и гинекология. — 1990. — № 7. — С. 41–45.
112. Полякова Г. П. Гемолитическая болезнь новорожденных при резус-сенсибилизации матерей переливанием крови // Акушерство и гинекология. — 1957. — № 3. — С. 9–13.
113. Шелаева Е. В., Павлова Н. Г. Перинатальные исходы при лечении тяжелых форм изоиммунизации // Журнал акушерства и женских болезней. — 2010. — № 5. — С. 44–50.
114. Assesment of fetal blood volume for computer-assisted management of in utero transfusion / Mandelbrot L. [et al.] // Fetal therapy. — 1988. — Vol. 3. — P. 60–66.
115. Bang J., Bock J. E., Trolle D. Ultrasound-guided fetal intravenous transfusion for severe rhesus haemolytic disease // Br. Med. J. — 1982. — Vol. 284. — P. 373–374.
116. Bowman J. M. Тhе prevention of Rh immunization // Transfusion Medicine Reviews. — 1988. — Vol. 2. — P. 129–150.
117. Bowman J. M., Pollock J. M. Transplacental fetal hemorrhage after amniocentesis // Obstet. Gynec. — 1985. — Vol. 66. — P. 749–754.
118. Chrown B. Anemia from bleeding of the fetus into the mother`s circulation // Lancet. — 1954. — Vol. 1. — P. 1213–1215.
119. Direct intravascular fetal blood transfusion by fetoscopy in severe Rhesus isoimmunization / Rodeck C. H. [et al.] // Lanset. — 1981. — Vol. 1. — P. 625–627.
120. Duguid J. K. M., Bromilow I. M. Laboratory measurement of fetomaternal haemorrhage and its clinical relevance // Transfusion Medicine Reviews. — 1999. — Vol. 13. — P. 43–48.
121. Everett C. Incidence and outcome of bleeding before the 20th week of pregnancy: prospective study of general practice // Br. Med. J. — 1997. — Vol. 315. — P. 32–34.
122. Experimental studies on the preventation of Rh haemolytic disease / Finn R. [et al.] // Br. Med. J. — 1961. — Vol. 1 (5238). — P. 1486–1490.
123. Fetal and neonatal hematologic parameters in red cell alloimmunization: prediction the need for late neonatal transfusions / Saade G. R. [et al.] // Fetal Diagnosis and Therapy. — 1993. — Vol. 8. — P. 161–164.
124. Fetal plasma cortisol and beta-endorphin response to intrauterine needling / Giannakoulopoulos X. [et al.] // Lanset. — 1994. — Vol. 344. — P. 77–81.
125. Gunson H. H. Neonatal anemia due to fetal hemorrhage into the maternal circulation // Pediatrics. — 1957. — Vol. 20. — P. 3–6.
126. Helper Т-сеll epitopes on the RhD protein — towards а peptide vaccine for prevention of Rh disease / Stott L. M. [et al.] // Transfusion Medicine. — 1999. — Vol. 9, suppl. 1. — P. 54.
127. Human fetal and maternal noradrenaline responses to invasive procedures / Giannakoulopoulos X. [et al.] // Pediatric Research. — 1999. — Vol.45. — P. 494–499.
128. Intrauterine transfusion — intraperitoneal versus intravascular approach: case-control comparison / Harman C. R. [et al.] // Am. J. Obstet. Gynecol. — 1990. — Vol. 162. — P. 1053– 1059.
129. Lasker M. R., Eddleman K., Tool A. H. Neonatal hepatitis and excessive hepatic iron deposition following intrauterine transfusion // Am. J. Perinatol. — 1995. — Vol. 12. — P. 14–17.
130. Liley A. W. Intrauterine transfusion of foetus in haemolytic disease // Brit. Med. J. — 1963. — Vol. 2. — P. 1107–1109.
131. Management of hemolytic disease by cordocentesis. II. Outcome of treatment / Weiner C. P. [et al.] // Am. J. Obstet. Gynec. — 1991. — Vol. 165. — P. 1302–1307.
132. Martin J. R. A double catheter technique for exchange transfusion in the newborn infant // New Zealand Med. J. — 1978. — Vol. 77. — P. 167–169.
133. Maternal serum alphafetoprotein after placental damage in chorionic villus sampling / Rodeck C. H. [et al.] // Lancet. — 1993. — Vol. 341. — P. 500.
134. McMaster Conference. Conference on prevention of Rh immunization // Von Sanguinis. — 1979. — Vol. 36. — P. 56–64.
135. Mollison P. L., Engelfriet C. P., Contreras M. Blood Transfusion in Clinical Medicine. — 10th edn. — Oxford: Blackwell Scientific Publications, 1997.
136. Nicolaides K. H., Clewell W., Rodeck C. H. Measurement of human fetoplacental blood volume in erythroblastosis fetalis // Am. J. Obstet. Gynecol. — 1987. — Vol. 157. — P. 50–53.
137. Outcome for children treated with fetal intravascular transfusions because of severe blood group fntagonism / Janssens H. M. [et al.] // J. Pediatrics. — 1997. — Vol. 131. — P. 373–380.
138. Ovali F., Samanci N., Dagoglu T. Management of late anemia in Rhesus hemolytic disease: use of recombinant human erythropoietin (a pilot study) // Pediatric Research. — 1996. — Vol. 39. — P. 831–834.
139. Prevention of Rh sensitization. World Health Organization. Technical Report Series. — Geneva, 1971. — 468 p.
140. Prevention of Rh-haemolytic desease: a third report / Woodrow J. C. [et al.] // Br. Med. J. — 1965. — Vol. 1. — P. 279–283.
141. Rh disease: intravascular fetal blood transfusion by cordocentesis / Nicolaides K. H. [et al.] // Fetal therapy. — 1986. — Vol. 1. — P. 185–192.
142. Risk factors for cоrdocentesis and fetal intravascular transfusion / Weiner C. P. [et al.] // Am. J. Obstet. Gynecol. — 1991. — Vol. 165. — P. 1020–1025.
143. Robinson A. E., Tovey L. A. Intensive plasma exchange in the management of severe Rh disease // Br. J. Haematology. — 1980. — Vol. 45. — P. 621–631.
144. Schur P. H., Alpert E., Alpert C. Gamma G subgroups in human fetal, cord and maternal sera // Clin. Immunology and Immunotherapy. — 1973. — Vol. 2. — P. 62–66.
145. The severely anemic and hydropic isoimmune fetus: changes in fetal hematocrit associated with intrauterine death / Radunovick N. [et al.] // Obstet.Gynec. — 1992. — Vol. 79. — P. 390–393.
146. Torrence G. W., Zipursky A. Cost-effectiveness of antepartum prevention of Rh immunization // Clinical Perinatology. — 1984. — Vol. 11. — P. 267–281.
2. Акушерство: учебник для медицинских вузов / Э. К. Айламазян [и др.]. — 6 е изд. — СПб.: Спецлит, 2007. — 528 с.
3. Минеева Н. В. Группы крови человека. Основы иммуногематологии. — СПб., 2004. — 188 с.
4. Сидельникова В. М., Антонов А. Г. Гемолитическая болезнь плода и новорожденного. — М.: Триада-Х, 2004. — 191 с.
5. Analysis of immunoglobu1lin class, IgG subclass and titre of НРА-lа antibodies in alloimmunized mothers giving birth to babies with or without neonatal alloimmune thrombocytopenia / Proulx С. [et al.] // Br. J. Haematology. — 1994. — Vol. 87. — P. 813–817.
6. Anti-D concentration in mother and child in haemolytic disease of the newborn / Hughes-Jones N. C. [et al.] // Vox Sanguinis. — 1971. — Vol. 21. — P. 135–140.
7. Anti-D сonсentrations in fetal and maternal serum and amniotiс fluid in rhesus allo-immunised pregnaneies / Eсonomides D. L. [et al.] // Br. J. оf Obstet. and Gynaecol. — 1993. — Vol. 100. — P. 923–926.
8. Antigen topography is critical for interaction of IgG2 anti-redcell antibodies with Fсγ receptors / Kumpel В. М. [et al.] // Br. J. оf Haematology. — 1996. — Vol. 94. — P. 175–183.
9. Billington W. D. The normal fetomaternal immune relationship // Bailliere’s Clinics Obstet. Gynaecol. — 1992. — Vol. 6. — P. 417–438.
10. Blockade of clearance of immune complexes bу аn аnti-FсR mоnосlоnаl antibody / Clarkson S. В. [et al.] // J. Experim. Medicine. — 1986. — Vol. 164. — P. 474–489
11. Clinical significance of IgG Fс receptors and FcγR-dirесtеd immunotherapies / Dео Y. М. [et al.] // Immunology Today. — 1997. — Vol. 18. — P. 127–135.
12. Correlation of serological, quаntitativе and cell-mediated functional assays of maternal alloantibodies with the severity of haemolytic disease of the newborn / Hadley A. G. [et al.] // Br. J. оf Haematology. — 1991. — Vol. 77. — P. 221–228.
13. Daniels G. L., Hadley A. G., Green С. А. Fetal anaemia due to anti-K mау result from immune destruction of early erythroid progenitors // Transfusion Medicine. — 1999. — Vol. 9, suppl. 1. — P. 16.
14. Davenport R. D., Kunkel S. L. IgG receptor roles in red сеll binding to monocytes and macrophages // Transfusion. — 1994. — Vol. 34. — P. 795.
15. Denomme G., Ryan G., Fernandes В. The FcγRIIa-Нisl3l allotype is overexpressed in infants with АBO hemolytic disease of the newborn // Вlood. — 1997. — Vol. 90. — P. 472–473.
16. Detection of fetal erythrocytes in maternal blood postpartum with the fluorescence-activated сеll sorter / Medearis A. L. [et al.] // Am. J. оf Obstet. Gynecol. — 1984. — Vol. 148. — P. 290–295.
17. Dooren М. С., Engelfriet С. Р. Protection against RhDhаеmоlуtic disease of the newborn bу а diminished transport of maternal IgG to the fetus // Vox Sanguinis. — 1993. — Vol. 65. — P. 59–6l.
18. Erythropoietic suppression in fetal anaemia because of Kell alloimmunization / Vaughan J. L. [et al.] // Am. J. Obstet. Gynecol. — 1994. — Vol. 171. — P. 247–52.
19. Galactosylation of human IgG monoclonal anti-D produced bу EBV-transformed В lymphoblastoid lines is dependent оn culture method and affects Fcγ receptor-mediated functional activity / Кumреl В. М. [et al.] // Нumаn Antibodies and Hybridomas. — 1994. — Vol. 5. — P. 143–151.
20. Ghetie V., Ward E. S. FcRn, the МНС class I related receptor that is more than аn IgG transporter // Immunology Today. — 1997. — Vol. 18. — P. 592–598.
21. Hilden J. O., Gottvall Т., Lindblom В. HLA phenotypes and severe Rh (D) immunization // Tissue Antigens. — 1995. — Vol. 46. — P. 3131–3315.
22. Hulett М. О., Hogarth Р. М. Molecular basis of Fc receptor function // Advances Immunology. — 1994. — Vol. 57. — P. 1–127.
23. Human IgG subclasses in maternal and fetal serum / Morell А. [et al.] // Vox Sanguinis. — 1971. — Vol. 21. — P. 481–492.
24. Inhibition of the monocyte chemiluminescent response to anti-D sensitized red cells bу Fcγ receptor I blocking antibodies which ameliorate the severity of haemolytic disease of the newborn / Shepard S. L. [et al.] // Vох Sanguinis. — 1996. — Vol. 70. — P. 157–163.
25. Jefferis R., Lund J., Pound J. D. IgG-Fc-mеdiаtеd effector functions, molecular definition of interaction sites for effector ligands and the role of glycosylation // Immunology Reviews. — 1998. — Vol. 163. — P. 59–76.
26. Kohler Р. F., Fаrr R. S. Elevation of cord over maternal IgG immunoglobulin: evidence for an active placental IgG transport // Nature. — 1966. — Vol. 210. — P. 1070–1071.
27. Kurlander R. J. Вlockade of Fc receptor-mediated binding to U 937 cells bу murine monoclonal antibodies directed against а variety of surface antigens // J. of Immunology. — 1983. — Vol. 131. — P. 140–147.
28. Lubenko А., Contreras М., Rodeck С. Н. Transplacental IgG subclass concentrations in pregnancies at risk of haemolytic disease of the newborn // Vox Sanguinis. — 1994. — Vol. 67. — P. 291–298.
29. Male fetuses are раrtiсulаrlу affected bу maternal аllоimmunizаtiоn to D antigen / Ulm В. [et al.] // Transfusion. — 1999. — Vol. 39. — P. 169–173.
30. Mapping the site оn human IgG for binding of the МНС class I related receptor, FcRn / Kim J K. [et al.] // Еur. J. Immunology. — 1999. — Vol. 29. — P. 2819–2825.
31. Maternal antibodies against fetal blood group antigens А or В, lytic activity of IgG subclasses in monocyte-driven cytotoxicity and correlation with АBO haemolytic disease of the newborn / Brouwers Н. А. [et al.] // Br. J. Haematology. — 1988. — Vol. 70. — P. 465–469.
32. Misleading results in the determination of haemolytic disease of the newborn using antibody titration and ADCC in а woman with anti-Lub / Novotny V. M.J. [et al.] // Vox Sanguinis. — 1992. — Vol. 62. — P. 49–52.
33. Molecular basis for а polymorphism of human FcγRII (CD32) / Warmerdam Р. А. М. [et al.] // J. Experim. Medicine. — 1990. — Vol. 172. — P. 19–25.
34. Nance S. J., Arndt Р. А., Gаrrаttу G. Соrrеlаtiоn of IgG subсlаss with the severity of hemolytic disease of the newborn // Transfusion. — 1990. — Vol. 30. — P. 381–382.
35. Parinaud J. [et al.] IgG subclasses and Gm allotypes of anti-D antibodies during pregnancy: correlation with the gravity of fetal disease // Am. J. Obstet. and Gynecol. — 1985. — Vol. 151. — P. 1111–1115.
36. Pollock J. M., Bowman J. M. Аnti-Rh (D) IgG subclasses and severity of Rh hemolytic disease of the newborn // Vox Sanguinis. — 1990. — Vol. 59. — P. 176–179.
37. Protection against immune haemolytic disease of newborn infants bу maternal monocyte-reactive IgG alloantibodies (anti HLA-DR) / Dooren М. С. [et al.] // Lancet. — 1992. — Vol. 339. — P. 1067–1070.
38. Ramsey G., Sherman L. A. Anti-D in pregnancy: value of antibody titres and effect of fetal gender // Transfusion. — 1999. — Vol. 39. — P. 105.
39. Ravetch J. V., Perussia В. Alternative membrane forms of FcγRIII (CDI6) оn human NK cells and neutrophils, celltype specific expression of two genes which differ in single nucleotide substitutions // J. Experim. Medicine. — 1989. — Vol. 170. — P. 481–491.
40. Renkonen К. О., Seppala М. Тhе sex of the sensitizing Rhpositive child // Annals оf Medicine. — 1962. — Vol. 40. — P. 108–118.
41. Renkonen К. О., Timonen S. Factors influencing the immunization of Rh-negative mothers // J. оf Medical Genetics. — 1967. — Vol. 4. — P. 166–176.
42. Rhesus Du incompatibility in а newborn with high levels of anti-D and а benign clinical course / Dias R. [et al.] // Vox Sanguinis. — 1986. — Vol. 50. — P. 52–53.
43. Rochna Е., Hughes-Jones N. C. Thе use of рurifiеd 125I-labelled anti-γ globu1lin in the determination of the number of D antigen sites оn red cells of different phenotypes // Vox Sanguinis. — 1965. — Vol. 10. — P. 675–686.
44. Selective placental transport of maternal IgG to the fetus / Williams P. J. [et al.] // Placenta. — 1995. — Vol. 16. — P. 749–756.
45. Shepard S. L., Hadley A. G. Monocyte-bound monoclonal antibodies inhibit the FcγRI-mеdiаtеd phagocytosis of red cells: the efficiency and mechanism of inhibition are determined bу the nature of the antigen // Immunology. — 1997. — Vol. 90. — P. 314–322.
46. Skidmore I., Hadley A. G. The effect of specificity оn the functional activity of red cеll-bound blood group antibodies // Transfusion Medicine. — 1996. — Vol. 6, suppl. 2. — P. 26.
47. Story С. М., Mikulska J. E., Simister N. E. А major histocompatibility complex class I like Fc receptor cloned from human placenta: possible role in transfer of immunoglobulin G from mother to fetus // J. Experim. Medicine. — 1994. — Vol. 180. — P. 2377–2381.
48. Taslimi М. М. [et al.] Immunoglobulin G subclasses and isoimmunized pregnancy оutсоmе // Am. J. оf Obstet. and Gynecol. — 1986. — Vol. 154. — P. 1327–1332.
49. The alloreactive and autoreactive Т helper cytokine responses to the RhD protein differ / Наll А. М. [et al.] // Transfusion Medicine. — 1999. — Vol. 9, suppl. 1. — P. 17.
50. The expression of IgG Fc receptors оn circulating leucocytes in the fetus and new-born / Mawas Р. [et al.] // Transfusion Medicine. — 1994. — Vol. 4. — P. 25–33.
51. Urbaniak S. J., Greiss М. А. АDСС (K cell) lysis of human erythrocytes sensitized with Rhesus alloantibodies. III. Comparison of IgG anti-D agglutinating and lytic (ADCC) activity and the role of IgG subclasses // Br. J. оf Haematology. — 1980. — Vol. 46. — P. 447–453.
52. Viеtоr Н. Е., Kanhai Н. Н. Н., Brand А. Induction of additional red сеll alloantibodies after intrauterine transfusions // Transfusion. — 1994. — Vol. 34. — P. 970–974.
53. Woodrow J. C. Rh immunisation and its prevention // Ser. Haematol. –1970. — Vol. 3, N 3. — P. 1–151.
54. Woodrow J. С., Finn R. Transplacental haemorrhage // Br. J. Haematology. — 1966. — Vol. 12. — P. 297–307.
55. Wu S., Maslanka К., Gorski J. Аn integrin polymorphism that defines reactivity with alloantibodies generates an anchor for МНС class II peptide binding: а model for unindirectional alloimmune responses // J. Immunology. — 1997. — Vol. 158. — P. 3221–3226.
56. Zuраnskа В. [et al.] Serological and immunological characteristics of maternal аnti-Rh (D) antibodies in predicting the severity of haemolytic disease of the newborn // Vox Sanguinis. — 1989. — Vol. 56. — P. 247–253.
57. Вuх J. Nomenclature of granulocyte alloantigens // Transfusion. — 1999. — Vol. 39. — P. 662–663.
58. Кumpel В. М., Hadley A. G. Functional interactions of red cells sensitised bу IgG1 and IgG3 human mоnосlоnаl anti-D with enzyme-modified human monocytes and FcR-bеаring cell lines // Molecular Immunology. — 1990. — Vol. 27. — P. 247–256.
59. Мurrау S., Knox E. G., Walker W. Rhesus haemolytic disease of the newborn and the АВО groups // Vox Sanguinis. — 1965. — Vol. 10. — P. 6–31.
60. Моnоnuсlеаr phagocyte assays, AutoAnalyzer quantitation and IgG subclasses of maternal аnti-RhD in the prediction of the severity of haemolytic disease in the fetus before 32 weeks gestation / Garner S. F. [et al.] // Br. J. оf Haematology. — 1992. — Vol. 80. — P. 97–101.
61. Айламазян Э. К. Кордоцентез в антенатальной диагностике, терапии и хирургии болезней плода // Вестник РАМН. — 1998. — № 1. — С. 6–11.
62. Айламазян Э. К., Павлова Н. Г. Современные представления о патогенезе и ультразвуковой диагностике анемии у плода // Пренатальная диагностика. — 2007. — Т. 6, № 3. — С. 175–179.
63. Акушерство: национальное руководство / ред. Э. К. Айламазян, В. И. Кулаков, В. Е. Радзинский, Г. М. Савельева. — М.: ГЭОТАР — Медиа, 2007. –1200 с.
64. Конопляников А. Г. Новые технологии в диагностике, лечении и профилактике гемолитической болезни плода и новорожденного: автореф. дис… д ра мед.наук. — М., 2009. — 48 с.
65. Кордоцентез: четырехлетний опыт применения в целях пренатальной диагностики и лечения заболеваний плода / Айламазян Э. К. [и др.] // Ультразвук. Диагностика в акуш., гин. и перинат. — 1993. — № 3. — С. 33–39.
66. Михайлов А. В. Объем печени плода: методы определения на основе ультразвукового исследования, изменения во второй половине неосложненной беременности // Акушерство и гинекология. — 1990. — № 5. — С. 49–51.
67. Нагорнева С. В. Диагностика тяжелых форм гемолитической болезни плода: автореф. дис… канд. мед.наук. — СПб., 2010. — 28 с.
68. Павлова Н. Г., Коган И. Ю., Константинова Н. Н. Кардиотокография: учебно-методическое пособие / ред. Э. К. Айламазян. — СПб.: Изд-во Н Л, 2009. — 28 с.
69. Павлова Н. Г., Шелаева Е. В., Нагорнева С. В. Допплерометрия мозгового кровотока плода для диагностики тяжелых форм гемолитической болезни // Пренатальная диагностика. — 2007. — Т. 6, № 3. — С. 175–179.
70. Панина О. Б. Ультразвуковая плацентометрия в диагностике нарушений состояния плода: автореф. дис… канд.мед. наук. — М., 1989.
71. Порядок проведения иммуногематологических исследований у беременных, рожениц, плодов и новорожденных: методическое письмо Минздравсоцразвития РФ. — М., 2008. — 22 с.
72. Ультразвуковая плацентометрия во время беременности / Сичинава Л. Г. [и др.] // Акушерство и гинекология. — 1989. — № 9. — С. 32–35.
73. Эхография в акушерстве и гинекологии. Теория и практика: пер. с англ. В 2 х ч. Ч. 2 / Под ред. А. Флейшнера [et al.]. — 6 е изд. — М.: Видар, 2004.
74. Alloimmune disorders of pregnancy: anaemia, thrombocytopenia and neutropenia in the fetus and newborn / eds. A. G. Hadley, P. Soothill. — Cambridge: University Press, 2005. — 282 p.
75. Anath U., Queenan J. T. Does midtrimester delta OD450 of amniotic fluid reflect severity of Rh-desease? // Am. J. Obstet. Gynecol. — 1989. — Vol. 161. — P. 47–49
76. Bevis D. The composition of liquor amnii in haemolytic disease of the newborn // Br. J. Obstet.Gynecol.Emp. — 1953. — Vol. 60. — P. 244–251.
77. Can a single measurement of amniotic fluid delta optical density be safely used in the clinical management of Rhtsus-alloimmunized pregnancies before 27 weeks’ gestation? / Rahman F. [et al.] // Acta Obstet. Gynecol. Scand. — 1998. — Vol.77. — P. 804–807.
78. Clinics in Perinatology / ed. M. K. Smith. — Philadelphia: Saunders, 1989.
79. Comparison of different reference values of fetal blood flow velocity in the middle cerebral artery for predicting fetal anemia / Barthra J. L. [et al.] // Ultrasound Obstet. Gynecol. — 2005. — Vol. 25. — P. 335–340.
80. Correction of fetal anemia on the middle cerebral artery peak systolic velocity / Stefos T. [et al.] // Obstet. Gynecol. — 2002. — Vol. 99. — P. 211–215.
81. Correlation between middle cerebral artery peak systolic velocity and fetal hemoglobin after 2 previous intrauterine transfusions / Mari G. [et al.] // Obstet. Gynecol. — 2005. — Vol. 193. — P. 1117–1120.
82. De Vore G. R. The prenatal diagnosis of congenital heart disease: A practical approach for the fetal sonographer // J. Clin. Ultrasound. — 1985. — Vol. 13. — P. 229–245.
83. Diagnosis of fetal anemia with Doppler ultrasound in the pregnancy complicated by maternal blood group immunization / Mari G. [et al.] // Ultrasound Obstet.Gynecol. — 1995. — Vol. 5. — P. 400–405
84. Doppler ultrasonography versus amniocentesis to predict fetal anemia / Oepkes D. [et al.] // N. Engl. J. Med. — 2006. — Vol. 355, № 2. — P. 156–164.
85. Failure of ultrasonographic parameters to predict the severity of fetal anemia in rhesus isoimmunization / Nicolaides K. H. [et al.] // Am. J. Obstet. Gynecol. — 1988. — Vol. 58. — P. 920.
86. Fetal Haemoglobin measurement in the assessment of red cell isoimmunization / Nicolaides K. H. [et al.] // Lancet. — 1988. — Vol. 1. — P. 1073–1075.
87. Have Liley charts outlived their usefulness? / Nicolaides K. H. [et al.] // Am. J. Obstet. Gynecol. — 1986. — Vol. 155. — P. 90–94.
88. Increase of fetal hematocrit decreases the middle cerebral artery peak systolic velocity in pregnancies complicated by rhesus alloimmunization / Mari G. [et al.] // J. Matern. Fetal Med. — 1997. — Vol. 6. — P. 206–208.
89. Liley A. W. Liquor amnii analysis in the management of pregnancy complicated by rhesus sensitization // Am. J. Obstet. Gynecol. — 1961. — Vol. 82. — P. 1359–1370.
90. Management pregnancies complicated by anti-c isoimmunization / Hackney D. N. [et al.] // Obstet. Gynecol. — 2004. — Vol. 103. — P. 24–30.
91. Mari G. Middle cerebral artery peak systolic velocity: is it the standard of care for the diagnosis of fetal anemia // J. Ultrasound Med. — 2005. — Vol. 24. — P. 697–702.
92. Mari G. Noninvasive diagnosis by Doppler ultrasonography of the fetal anaemia due to maternal red-cell alloimmunization // New England J. — 2000. — Vol. 342. — P. 9–14.
93. Mari G. Opinion. Middle cerebral artery peak systolic velocity for the diagnosis of fetal anemia: the untold story // Ultrasound Obstet. Gynecol. — 2005. — Vol. 25. — P. 323–330.
94. Middle cerebral artery peak systolic and ductus venosus velocity waveforms in the hydropic fetus / Cosmi E. [et al.] // J. Ultrasound Med. — 2005. — Vol. 24. — P. 209–213.
95. Middle cerebral artery peak systolic velocity: technique and variability / Mari G. [et al.] // J. Ultrasound Med. — 2005. — Vol. 24. — P. 425–430.
96. Minimally invasive management of rhesus isoimmunization: can amniotic fluid delta OD450 be replaced by Doppler studies? A prospective multicenter trial / Oepkes D. [et al.] // Am. J. Obstet. Gynecol. — 2004. — Vol. 191, suppl. — P. S2.
97. Moise K. J. Management of resus alloimmunization in pregnancy // Obstet. Gynecol. — 2008. — Vol. 112, № 1. — P. 164–176
98. Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. Collaborative group for Doppler Assessment of the Blood Velocity in Anemic Fetuses / Mari G. [et al.] // N. Engl. J. Med. — 2000. — Vol. 342. — P. 9–14
99. Noninvasive diagnosis of fetal anemia by doppler ultrasonography / Nagey D. A. [et al.] // N. Engl. J. Med. — 2000. — Vol. 343. — P. 66–68.
100. Non-invasive tests to predict fetal anemia in Kell-alloimmunised pregnancies / Van Dongen H. [et al.] // Ultrasound Obstet. Gynecol. — 2005. — Vol. 25. — P. 341–345.
101. Pereira L., Jenkins Th., Berghella V. Convertional management of maternal red cell alloimmunization compared with management by Doppler assessment of middle cerebral artery peak systolic velocity // Am. J. Obstet. Gynecol. — 2003. — Vol. 189. — P. 1002–1006.
102. Plasmapheresis in Rh hemolytic disease, the danger of amniocentesis / Grant C. J. [et al.] // Int. J. Artificial Organs. — 1983. — Vol. 6. — P. 83–86.
103. Prediction of severe fetal anemia in red blood cell alloimmunization after previous intrauterine transfusions / Scheier M. [et al.] // Obstet. Gynecol. — 2006. — Vol. 195. — P. 1550–1556.
104. Pulsed doppler flow-velocity waveforms before and after intrauterine intravascular transfusion for severe erythroblastosis fetalis / Copel J. A. [et al.] // Am. J. Obstet. Gynecol. — 1988. — Vol. 158. — P. 768–774.
105. Queenan J. Т. Amniocentesis and isoimmunization // Rh Hemolytic Disease. New Strategy for Eradication / eds. F. D. Frigoletto, J. F. Jewette, А. A. Kongugres. — Boston: Наll Medical, 1982. — P.125–134.
106. Ultrasonographic fetal spleen measurements in red cell alloimmunized pregnancies / Oepkes D. [et al.] // Am. J. Obstet. Gynecol. — 1993. — Vol. 169. — P. 121–128.
107. Wong G., Levine D. Increased systolic peak velocity in fetal middle cerebral artery blood flow shown by doppler sonography in acute fetomaternal hemorrhage // J. Ultrasound Med. — 2005. — Vol. 24. — P. 243–246.
108. Акушерство: национальное руководство / ред. Э. К. Айламазян, В. И. Кулаков, В. Е. Радзинский, Г. М. Савельева. — М.: ГЭОТАР — Медиа, 2007. — 1200 с.
109. Васильева З. Ф. Антиген-несовместимая беременность и методы защиты плода и новорожденного при иммунологическом конфликте: автореф. дис… д-ра мед. наук. — Л., 1972.
110. Кордоцентез: четырехлетний опыт применения в целях пренатальной диагностики и лечения заболеваний плода / Айламазян Э. К. [и др.] // Ультразвук. Диагностика в акуш., гин. и перинат. — 1993. — № 3. — С. 33–39.
111. Михайлов А. В., Константинова Н. Н., Пигина Т. В. Внутриматочные переливания как способ лечения отечной формы гемолитической болезни плода // Акушерство и гинекология. — 1990. — № 7. — С. 41–45.
112. Полякова Г. П. Гемолитическая болезнь новорожденных при резус-сенсибилизации матерей переливанием крови // Акушерство и гинекология. — 1957. — № 3. — С. 9–13.
113. Шелаева Е. В., Павлова Н. Г. Перинатальные исходы при лечении тяжелых форм изоиммунизации // Журнал акушерства и женских болезней. — 2010. — № 5. — С. 44–50.
114. Assesment of fetal blood volume for computer-assisted management of in utero transfusion / Mandelbrot L. [et al.] // Fetal therapy. — 1988. — Vol. 3. — P. 60–66.
115. Bang J., Bock J. E., Trolle D. Ultrasound-guided fetal intravenous transfusion for severe rhesus haemolytic disease // Br. Med. J. — 1982. — Vol. 284. — P. 373–374.
116. Bowman J. M. Тhе prevention of Rh immunization // Transfusion Medicine Reviews. — 1988. — Vol. 2. — P. 129–150.
117. Bowman J. M., Pollock J. M. Transplacental fetal hemorrhage after amniocentesis // Obstet. Gynec. — 1985. — Vol. 66. — P. 749–754.
118. Chrown B. Anemia from bleeding of the fetus into the mother`s circulation // Lancet. — 1954. — Vol. 1. — P. 1213–1215.
119. Direct intravascular fetal blood transfusion by fetoscopy in severe Rhesus isoimmunization / Rodeck C. H. [et al.] // Lanset. — 1981. — Vol. 1. — P. 625–627.
120. Duguid J. K. M., Bromilow I. M. Laboratory measurement of fetomaternal haemorrhage and its clinical relevance // Transfusion Medicine Reviews. — 1999. — Vol. 13. — P. 43–48.
121. Everett C. Incidence and outcome of bleeding before the 20th week of pregnancy: prospective study of general practice // Br. Med. J. — 1997. — Vol. 315. — P. 32–34.
122. Experimental studies on the preventation of Rh haemolytic disease / Finn R. [et al.] // Br. Med. J. — 1961. — Vol. 1 (5238). — P. 1486–1490.
123. Fetal and neonatal hematologic parameters in red cell alloimmunization: prediction the need for late neonatal transfusions / Saade G. R. [et al.] // Fetal Diagnosis and Therapy. — 1993. — Vol. 8. — P. 161–164.
124. Fetal plasma cortisol and beta-endorphin response to intrauterine needling / Giannakoulopoulos X. [et al.] // Lanset. — 1994. — Vol. 344. — P. 77–81.
125. Gunson H. H. Neonatal anemia due to fetal hemorrhage into the maternal circulation // Pediatrics. — 1957. — Vol. 20. — P. 3–6.
126. Helper Т-сеll epitopes on the RhD protein — towards а peptide vaccine for prevention of Rh disease / Stott L. M. [et al.] // Transfusion Medicine. — 1999. — Vol. 9, suppl. 1. — P. 54.
127. Human fetal and maternal noradrenaline responses to invasive procedures / Giannakoulopoulos X. [et al.] // Pediatric Research. — 1999. — Vol.45. — P. 494–499.
128. Intrauterine transfusion — intraperitoneal versus intravascular approach: case-control comparison / Harman C. R. [et al.] // Am. J. Obstet. Gynecol. — 1990. — Vol. 162. — P. 1053– 1059.
129. Lasker M. R., Eddleman K., Tool A. H. Neonatal hepatitis and excessive hepatic iron deposition following intrauterine transfusion // Am. J. Perinatol. — 1995. — Vol. 12. — P. 14–17.
130. Liley A. W. Intrauterine transfusion of foetus in haemolytic disease // Brit. Med. J. — 1963. — Vol. 2. — P. 1107–1109.
131. Management of hemolytic disease by cordocentesis. II. Outcome of treatment / Weiner C. P. [et al.] // Am. J. Obstet. Gynec. — 1991. — Vol. 165. — P. 1302–1307.
132. Martin J. R. A double catheter technique for exchange transfusion in the newborn infant // New Zealand Med. J. — 1978. — Vol. 77. — P. 167–169.
133. Maternal serum alphafetoprotein after placental damage in chorionic villus sampling / Rodeck C. H. [et al.] // Lancet. — 1993. — Vol. 341. — P. 500.
134. McMaster Conference. Conference on prevention of Rh immunization // Von Sanguinis. — 1979. — Vol. 36. — P. 56–64.
135. Mollison P. L., Engelfriet C. P., Contreras M. Blood Transfusion in Clinical Medicine. — 10th edn. — Oxford: Blackwell Scientific Publications, 1997.
136. Nicolaides K. H., Clewell W., Rodeck C. H. Measurement of human fetoplacental blood volume in erythroblastosis fetalis // Am. J. Obstet. Gynecol. — 1987. — Vol. 157. — P. 50–53.
137. Outcome for children treated with fetal intravascular transfusions because of severe blood group fntagonism / Janssens H. M. [et al.] // J. Pediatrics. — 1997. — Vol. 131. — P. 373–380.
138. Ovali F., Samanci N., Dagoglu T. Management of late anemia in Rhesus hemolytic disease: use of recombinant human erythropoietin (a pilot study) // Pediatric Research. — 1996. — Vol. 39. — P. 831–834.
139. Prevention of Rh sensitization. World Health Organization. Technical Report Series. — Geneva, 1971. — 468 p.
140. Prevention of Rh-haemolytic desease: a third report / Woodrow J. C. [et al.] // Br. Med. J. — 1965. — Vol. 1. — P. 279–283.
141. Rh disease: intravascular fetal blood transfusion by cordocentesis / Nicolaides K. H. [et al.] // Fetal therapy. — 1986. — Vol. 1. — P. 185–192.
142. Risk factors for cоrdocentesis and fetal intravascular transfusion / Weiner C. P. [et al.] // Am. J. Obstet. Gynecol. — 1991. — Vol. 165. — P. 1020–1025.
143. Robinson A. E., Tovey L. A. Intensive plasma exchange in the management of severe Rh disease // Br. J. Haematology. — 1980. — Vol. 45. — P. 621–631.
144. Schur P. H., Alpert E., Alpert C. Gamma G subgroups in human fetal, cord and maternal sera // Clin. Immunology and Immunotherapy. — 1973. — Vol. 2. — P. 62–66.
145. The severely anemic and hydropic isoimmune fetus: changes in fetal hematocrit associated with intrauterine death / Radunovick N. [et al.] // Obstet.Gynec. — 1992. — Vol. 79. — P. 390–393.
146. Torrence G. W., Zipursky A. Cost-effectiveness of antepartum prevention of Rh immunization // Clinical Perinatology. — 1984. — Vol. 11. — P. 267–281.
Поступление
30 Ноябрь 2017
Категории
Copyright (c) 2017 ООО "ЭКО-Вектор"
Детали об этой монографии
Co-publisher's ISBN-13 (24)
978-5-94869-147-3
Date of first publication (11)
06.05.2012
